Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

BACKGROUND: Ceftriaxone (CTRX) and ampicillin/sulbactam (ABPC/SBT) are recommended by various guidelines as the first-line antibiotics for community-acquired pneumonia (CAP). However, which of these antibiotics is more effective for treating non-aspiration CAP remains unclear. METHODS: This study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamao, Nobuyoshi, Ito, Isao, Konishi, Satoshi, Tanabe, Naoya, Shirata, Masahiro, Oi, Issei, Tsukino, Mitsuhiro, Matsumoto, Hisako, Yasutomo, Yoshiro, Kadowaki, Seizo, Hirai, Toyohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275365/
https://www.ncbi.nlm.nih.gov/pubmed/32503515
http://dx.doi.org/10.1186/s12890-020-01198-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275365/
https://www.ncbi.nlm.nih.gov/pubmed/32503515
http://dx.doi.org/10.1186/s12890-020-01198-4

Ejemplares similares